HAVN Life Sciences Inc. (HAVLF) Research

HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms. The company is also dedicated to establishing standardized, quality-controlled methodologies for extracting these psychoactive molecules, with a specific focus on Psilocybe mushroom species and their key constituents such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health products utilizing unregulated ingredients. Founded in 2020, HAVN Life Sciences' operations are headquartered in Richmond, Canada.

Market snapshot

Symbol
HAVLF
Price
$0.00
Day change
0.00%
Market cap
$1.2M
P/E ratio
-0.01x
52-week range
0.00001-0.01
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Ayala Pharmaceuticals, Inc. (ADXS)
  • Acrux Limited (ARUXF)
  • AXIM Biotechnologies, Inc. (AXIM)
  • Resilient Healthcare Corp (NRPR)
  • ProtoKinetix, Incorporated (PKTX)
  • RepliCel Life Sciences Inc. (REPCF)
  • Regen BioPharma, Inc. (RGBP)
  • Sigyn Therapeutics, Inc. (SIGY)

Open HAVN Life Sciences Inc. (HAVLF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.